Volv Global at Tech Tour Growth Health 2026
Tech Tour Growth Health is one of Europe’s most established gatherings at the intersection of healthcare innovation and investment – bringing together growth-stage digital health and medtech companies, leading investors, corporate partners, and ecosystem experts for two days of substantive exchange. This year’s edition takes place on 30 June – 1 July 2026 at IMD Business School in Lausanne, and Volv Global will be joining the cohort.
The event sits on our doorstep – we are based at Biopôle Épalinges, a short distance from the IMD campus – and it brings together a community we are glad to be part of. Over 50 active healthcare investors and 70 expert and corporate guests are expected this year, alongside a selected group of companies working across digital health and medtech. The programme combines structured sessions with dedicated one-to-one meetings: a format well suited to the kind of direct, substantive conversations we value most.
Our founder and CEO, Christopher Rudolf, will be representing Volv Global across both days – sharing perspectives on where AI and real-world data are genuinely moving the needle in rare and difficult-to-diagnose disease, and connecting with others in the ecosystem who are thinking seriously about the same questions.
If you are attending and would like to arrange a meeting with Christopher, please contact us.
Who is representing Volv Global at the event?
Volv Global CEO and founder Christopher Rudolf will be attending and is available to meet with pharmaceutical companies and life sciences organisations interested in learning more about Volv Global’s work.
How can I arrange a meeting with Volv Global at the event?
Please contact us ahead of 30 June and we will be glad to arrange a time to connect.
Volv Global is pleased to be participating in the Life Sciences Innovation & Investment Corridor…
The idea that an AI system could detect a disease that appears nowhere in a…
The ISPOR International Annual Conference 2026 brings together global leaders in health economics and outcomes…
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Inflammatory Bowel Disease (IBD) management has…
Introduction Advocacy plays a critical role in accelerating progress in rare diseases. As technology advances,…
As our commemoration of Rare Disease Day 2026, we are pleased to present a guest…